Back

TiumBio shares jump 11.90% after U.S. patent decision for Tospocertib therapy

Verifying
  • TiumBio announced U.S. patent registration for Tospocertib combination therapy.
  • TiumBio shares traded at 4,825 won, up 520 won or 11.90%.
  • The patent’s rights run through July 2042, or July 2043 with PTA.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.
TiumBio shares jump 11.90% after U.S. patent decision for Tospocertib therapy - CoinPost Terminal